# Asymptomatic COVID-19 Trial

> **NCT04374552** · PHASE2 · WITHDRAWN · sponsor: **Rutgers, The State University of New Jersey**

## Conditions studied

- SARS-CoV-2 Infection

## Interventions

- **DRUG:** Hydroxychloroquine sulfate &Azithromycin
- **DRUG:** Placebo

## Key facts

- **NCT ID:** NCT04374552
- **Lead sponsor:** Rutgers, The State University of New Jersey
- **Sponsor class:** OTHER
- **Phase:** PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** WITHDRAWN
- **Start date:** 2020-05-05
- **Primary completion:** 2020-11
- **Final completion:** 2021-04
- **Target enrollment:** 0 (ACTUAL)
- **Why stopped:** The investigators have decided not to go forward with this protocol
- **Last updated:** 2020-11-02


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04374552

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04374552, "Asymptomatic COVID-19 Trial". Retrieved via AI Analytics 2026-06-02 from https://api.ai-analytics.org/clinical/NCT04374552. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*